Skip to main content

Analysing Optical Coherence Tomography Angiography of Mid-Life Persons at Risk of Developing Alzheimer’s Disease Later in Life

  • Conference paper
  • First Online:
Ophthalmic Medical Image Analysis (OMIA 2022)

Abstract

Cerebrovascular changes associated with Alzheimer’s disease (AD) can occur years before the onset of symptoms. Studies have suggested that changes in the retina may act as a surrogate for cerebrovascular changes in the brain, hence the retina might be a source of biomarkers for declining vascular brain health. Optical Coherence Tomography Angiography (OCTA) is a promising retinal imaging modality that has been increasingly used to investigate cerebrovascular diseases in this context. However, the potential clinical translation of advances for early AD detection is still being explored. In this study, we used OCTA retinal phenotypes to investigate differences between participants with and without a high genetic risk characterization of Apoliproprotein E4 (APOE4), and between participants with and without a family history of dementia. Furthermore, we investigated whether there is a difference in OCTA retinal phenotypes between participants with and without a high CAIDE (Cardiovascular Risk Factors, Aging, and Dementia score). This investigation explored retinal phenotypes (from OCTA) both cross-sectionally and longitudinally (2 years follow-up) using participants at mid-life from the PREVENT cohort and our findings suggest that there are retinal vascular changes captured in OCTA images between control and participants at risk of developing AD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ali, N., et al.: Clinical validation of the RTVue optical coherence tomography angiography image quality indicators. Clin. Exp. Ophthalmol. 48(2), 192–203 (2020)

    Article  Google Scholar 

  2. Benjamini, Y., Hochberg, Y.: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc.: Ser. B (Methodol.) 57(1), 289–300 (1995)

    MathSciNet  MATH  Google Scholar 

  3. Blennow, K., Mattsson, N., Schöll, M., Hansson, O., Zetterberg, H.: Amyloid biomarkers in Alzheimer’s disease. Trends Pharmacol. Sci. 36(5), 297–309 (2015)

    Article  Google Scholar 

  4. Cortes-Canteli, M., Iadecola, C.: Alzheimer’s disease and vascular aging: JACC focus seminar. J. Am. Coll. Cardiol. 75(8), 942–951 (2020)

    Article  Google Scholar 

  5. Criscuolo, C., et al.: Assessment of retinal vascular network in amnestic mild cognitive impairment by optical coherence tomography angiography. PLoS ONE 15(6), e0233975 (2020)

    Google Scholar 

  6. Elahi, F.M., et al.: Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE \(\varepsilon \)4 gene carriers. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 13(1), e12181

    Google Scholar 

  7. Exalto, L.G., Quesenberry, C.P., Barnes, D., Kivipelto, M., Biessels, G.J., Whitmer, R.A.: Midlife risk score for the prediction of dementia four decades later. Alzheimer’s Dement. 10(5), 562–570 (2014)

    Google Scholar 

  8. Giarratano, Y., et al.: Automated segmentation of optical coherence tomography angiography images: benchmark data and clinically relevant metrics. Transl. Vis. Sci. Technol. 9(13), 5 (2020)

    Google Scholar 

  9. Giarratano, Y., et al.: A framework for the discovery of retinal biomarkers in optical coherence tomography angiography (OCTA). In: Fu, H., Garvin, M.K., MacGillivray, T., Xu, Y., Zheng, Y. (eds.) OMIA 2020. LNCS, vol. 12069, pp. 155–164. Springer, Cham (2020). https://doi.org/10.1007/978-3-030-63419-3_16

  10. Guerreiro, R., Bras, J.: The age factor in Alzheimer’s disease. Genome Med. 7(1), 1–3 (2015)

    Google Scholar 

  11. Hui, J., Zhao, Y., Yu, S., Liu, J., Chiu, K., Wang, Y.: Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer’s disease patients: a meta-analysis. PLoS ONE 16(8), e0255362 (2021)

    Google Scholar 

  12. Jack, C.R., et al.: A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87(5), 539–547 (2016)

    Google Scholar 

  13. Jack Jr., C.R., et al.: NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 14(4), 535–562 (2018)

    Google Scholar 

  14. Janeiro, M.H., et al.: Biomarkers in Alzheimer’s disease. Adv. Lab. Med./Avances en Medicina de Laboratorio 2(1), 27–37 (2021)

    Google Scholar 

  15. Khoury, R., Ghossoub, E.: Diagnostic biomarkers of Alzheimer’s disease: a state-of-the-art review. Biomark. Neuropsychiatry 1, 100005 (2019)

    Google Scholar 

  16. Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., Tuomilehto, J.: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 5(9), 735–741 (2006)

    Google Scholar 

  17. Liu, C.C., Kanekiyo, T., Xu, H., Bu, G.: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9(2), 106–118 (2013)

    Google Scholar 

  18. López-Cuenca, I., et al.: The value of oct and octa as potential biomarkers for preclinical Alzheimer’s disease: a review study. Life 11(7), 712 (2021)

    Google Scholar 

  19. Ma, J.P., et al.: Longitudinal analysis of the retina and choroid in cognitively normal individuals at higher genetic risk of Alzheimer disease. Ophthalmol. Retina 6, 607–619 (2022)

    Google Scholar 

  20. O’Bryhim, B.E., Apte, R.S., Kung, N., Coble, D., Van Stavern, G.P.: Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 136(11), 1242–1248 (2018)

    Google Scholar 

  21. O’Bryhim, B.E., Lin, J.B., Van Stavern, G.P., Apte, R.S.: OCT angiography findings in preclinical Alzheimer’s disease: 3-year follow-up. Ophthalmology 128(10), 1489–1491 (2021)

    Google Scholar 

  22. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C.P.: The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer’s Dement. 9(1), 63–75 (2013)

    Google Scholar 

  23. Rifai, O.M., et al.: The application of optical coherence tomography angiography in Alzheimer’s disease: a systematic review. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 13(1), e12149 (2021)

    Google Scholar 

  24. Ritchie, C.W., Ritchie, K.: The prevent study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer’s disease. BMJ Open 2(6), e001893 (2012)

    Google Scholar 

  25. Secomb, T.W.: Blood flow in the microcirculation. Annu. Rev. Fluid Mech. 49, 443–461 (2017)

    Article  MathSciNet  MATH  Google Scholar 

  26. Van De Kreeke, J.A., et al.: Optical coherence tomography angiography in preclinical Alzheimer’s disease. Br. J. Ophthalmol. 104(2), 157–161 (2020)

    Google Scholar 

  27. Wiseman, S.J., et al.: Measuring axial length of the eye from magnetic resonance brain imaging. BMC Ophthalmol. 22(1), 1–9 (2022)

    Google Scholar 

  28. Yoon, S.P., et al.: Retinal microvascular and neurodegenerative changes in Alzheimer’s disease and mild cognitive impairment compared with control participants. Ophthalmol. Retina 3(6), 489–499 (2019)

    Google Scholar 

Download references

Acknowledgment

DR was supported by a Medical Research Council Precision Medicine Doctoral Training Programme scholarship (MR/N013166/1)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Darwon Rashid .

Editor information

Editors and Affiliations

1 Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (pdf 15 KB)

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Rashid, D. et al. (2022). Analysing Optical Coherence Tomography Angiography of Mid-Life Persons at Risk of Developing Alzheimer’s Disease Later in Life. In: Antony, B., Fu, H., Lee, C.S., MacGillivray, T., Xu, Y., Zheng, Y. (eds) Ophthalmic Medical Image Analysis. OMIA 2022. Lecture Notes in Computer Science, vol 13576. Springer, Cham. https://doi.org/10.1007/978-3-031-16525-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-16525-2_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-16524-5

  • Online ISBN: 978-3-031-16525-2

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics